最亲 ○ 单季度 11月17日晚间，亚星化学发布公告称，公司股票于11月18日开市起复牌。截至11月18日9时45分，公司股票开盘后涨停封板报9.79元/股，今年来股价已翻 倍。 | 交易类型 | 交易对方名称 | | --- | --- | | 发行股份及支付现金购买资产 | 山东天一控股集团股份有限公司等24 名山东天 | | | 一化学股份有限公司股东 | | 募集配套资金 | 包括潍坊市城市建设发展投资集团有限公司在内 | | | 的不超过 35 名符合条件的特定对象 | 截至本预案签署日，本次交易的审计及评估工作尚未完成，标的资产估值及定价尚未确定。本次交易预计将达到《重组管理办法》规定的重大资产重组标 准，构成上市公司重大资产重组。 亚星化学表示，交易完成后，公司的主要产品将新增溴系列精细化工产品，包括四溴双酚A、溴化环氧树脂、溴化聚苯乙烯、十溴二苯乙烷、氢溴酸等，以 及标的公司新材料板块、钾盐板块、膜材料板块的各项产品。 值得一提的是，本次交易构成关联交易。本次发行股份及支付现金购买资产交易对方之一华潍人才系公司控股股东潍坊市城投集团权属企业，同时本次募集 配套资金的认购方包括公司控股股东潍坊市 ...

Core Viewpoint - Zhuhai Free Trade Group plans to sell 100% equity of Gree Real Estate to Toujie Holdings for a transaction price of 5.518 billion yuan, marking a significant asset restructuring move [1] Group 1: Transaction Details - The transaction price for the sale of Gree Real Estate is set at 5.518 billion yuan [1] - This transaction constitutes a major asset restructuring for Zhuhai Free Trade Group [1] - The stock of the company will be suspended from trading starting November 17 [1] Group 2: Strategic Focus - Following the transaction, Zhuhai Free Trade Group aims to accelerate its complete divestment from real estate and refocus on its core duty-free business within the large consumption sector [1] - The company plans to establish itself as a large consumption industry group based in the Guangdong-Hong Kong-Macau region, expanding its reach nationwide and internationally [1] - The company is entering a new phase of high-quality development with a strategic focus on large consumption [1] Group 3: Regulatory Requirements - The transaction is subject to approval from various regulatory bodies, including the Zhuhai State-owned Assets Supervision and Administration Commission, decision-making bodies of Toujie Holdings, the company's shareholders meeting, and the Shanghai Stock Exchange [1]

Core Viewpoint - The company, Yaxing Chemical, has announced a non-public issuance plan to acquire 100% equity of Tianyi Chemical from 24 shareholders, which is expected to constitute a major asset restructuring [1] Group 1: Acquisition Details - The acquisition will be financed through the issuance of shares and cash payments [1] - The company plans to issue shares to no more than 35 qualified specific investors, including Weifang City Investment Group, to raise supporting funds [1] Group 2: Product Expansion - Post-transaction, the company's main products will include a range of bromine series fine chemical products such as tetrabromobisphenol A, brominated epoxy resin, brominated polystyrene, decabromodiphenyl ether, and hydrobromic acid [1] - The acquisition will also enhance the company's product portfolio in new materials, potassium salts, and membrane materials [1] Group 3: Strategic Implications - This transaction is expected to improve the company's product layout and enhance its profitability [1]

停牌10个交易日后，11月17日晚间，亚星化学（600319）披露重组预案，公司拟通过发行股份及支付现金的方式购买天一控股等24名股东持有的天一化学 100%股权。同时，上市公司拟向包括潍坊市城投集团在内的不超过35名符合条件的特定投资者发行股份募集配套资金。 | 交易类型 | 交易对方名称 | | --- | --- | | 发行股份及支付现金购买资产 | 山东天一控股集团股份有限公司等 24 名山东天 | | | 一化学股份有限公司股东 | | 募集配套资金 | 包括潍坊市城市建设发展投资集团有限公司在内 | | | 的不超过 35 名符合条件的特定对象 | 公告显示，此次发行股份价格以定价基准日前120个交易日亚星化学A股股票交易均价的80%为依据，作价5.83元/股。 交易完成后，天一化学将成为上市公司全资子公司并纳入合并报表范围，公司控股股东仍为潍坊市城投集团，实际控制人仍为潍坊市国资委。 本次交易预计构成重大资产重组、构成关联交易、预计不构成重组上市。公司股票将于11月18日开市起复牌。 天一化学是国内溴系阻燃剂龙头供应商之一，是国家首批认定的高新技术企业、国家专精特新"小巨人"企业，业务涵盖溴系 ...

Core Viewpoint - Yaxing Chemical plans to acquire 100% equity of Tianyi Chemical, with stock resuming trading on November 18 after a two-week suspension [2]. Group 1: Acquisition Details - The board of Yaxing Chemical has approved the acquisition proposal, which is expected to constitute a major asset restructuring for the listed company [5]. - Tianyi Chemical, established in October 2002, specializes in the research, production, and sales of bromine series products, with some products holding the highest market share in China [5]. - Prior to the acquisition, Yaxing Chemical's main products included chlorinated polyethylene (CPE), polyvinylidene chloride (PVDC), and other chemical materials [5]. Group 2: Product and Market Impact - Post-acquisition, Yaxing Chemical will expand its product offerings to include bromine series fine chemical products such as tetrabromobisphenol A and brominated epoxy resin, enhancing its product layout and profitability [5]. - The acquisition is expected to solidify Yaxing Chemical's industry position and support its ongoing development [5]. Group 3: Financial Performance - In the first three quarters of the year, Yaxing Chemical reported revenue of 641 million yuan, a year-on-year decrease of 2.53%, and a net loss attributable to shareholders of 144 million yuan, down 46.4% year-on-year [5]. - Prior to the suspension, Yaxing Chemical's stock was priced at 8.9 yuan per share, with a total market capitalization of 3.451 billion yuan [5].

【导读】亚星化学拟收购天一化学100%股权，股票明日复牌 中国基金报记者 忆山 停牌两周后，11月17日， 亚星化学 发布公告称，公司董事会已审议通过了相关议案，公司 股票将于11月18日复牌。 根据公告，亚星化学拟通过发行股份及支付现金的方式购买天一控股等24名股东持有的山东 天一化学股份有限公司（以下简称天一化学）100%股权。同时，公司拟向包括潍坊市城投集 团在内的不超过35名符合条件的特定投资者发行股份募集配套资金。 截至预案签署日，本次交易的审计及评估工作尚未完成，标的资产估值及定价尚未确定。亚 星化学预计本次交易构成上市公司重大资产重组。 资料显示，天一化学成立于2002年10月，是一家专业从事溴系列产品研发、生产和销售的企 业。公司主要产品分为溴系阻燃剂、均相离子膜、水性功能材料及钾盐钾肥四大板块，部分 产品市场占有率全国第一。 本次交易前，亚星化学主营氯化聚乙烯（CPE）、聚偏二氯乙烯（PVDC）、离子膜烧碱、水 合肼、ADC发泡剂、双氧水等产品，同时从事新型化学材料的开发和研究。 | | | 交易完成后，亚星化学的主要产品将新增溴系列精细化工产品，包括四溴双酚A、溴化环氧树 脂、溴化聚苯乙烯 ...

Core Viewpoint - The company, Jiarong Technology, is planning to acquire control of Hangzhou Lanran Technology Co., Ltd. through a share issuance and is expected to raise supporting funds, which may constitute a significant asset restructuring. The company's shares have been suspended since November 17, and a transaction plan is expected to be disclosed within 10 trading days [1][7]. Group 1: Company Overview - Jiarong Technology is a national high-tech enterprise focused on membrane separation technology and was listed on the ChiNext board in April 2022 [3]. - The company has been engaged in high-concentration wastewater treatment since 2009 and provides high-performance separation membrane materials, environmental equipment, and solutions for resource recycling [4]. Group 2: Financial Performance - Jiarong Technology's financial performance has been underwhelming, with revenues of 755.6 million yuan, 555.5 million yuan, and 556 million yuan from 2022 to 2024, and net profits of 107 million yuan, 58.1 million yuan, and 50.2 million yuan during the same period [4]. - In the first three quarters of 2025, the company reported revenues of 362 million yuan, a year-on-year decrease of 7.53%, while net profit increased by 12.95% to 59.3 million yuan [4]. Group 3: Acquisition Target - Hangzhou Lanran is a national high-tech enterprise specializing in the research and application of electrodialysis technology, with a focus on ion exchange membranes and related equipment [5]. - The company held an 8.88% share of the global market for electrodialysis equipment in 2021, ranking third, and maintained a leading position in the domestic market with a 41.27% share [6]. Group 4: IPO Attempt and Regulatory Issues - Hangzhou Lanran attempted to go public on the ChiNext board in June 2022 but withdrew its application in December 2022 after facing regulatory inquiries regarding its financial disclosures and operational practices [7][12]. - The company received a regulatory letter from the Shenzhen Stock Exchange in May 2023, citing violations related to income recognition and financial internal controls during its IPO application process [14].

Core Viewpoint - Yaxing Chemical (600319) announced a major asset restructuring plan, intending to acquire 100% equity of Tianyi Chemical from 24 shareholders through a combination of share issuance and cash payment, with trading resuming on November 18 [1] Group 1: Transaction Details - The transaction is expected to constitute a significant asset restructuring and related party transaction, but it will not qualify as a restructuring listing [1] - Yaxing Chemical plans to raise supporting funds by issuing shares to no more than 35 qualified specific investors, including Weifang City Investment Group [1] Group 2: Business Impact - Tianyi Chemical operates in four main sectors: flame retardants, new materials, potassium salts, and membrane materials, and is a leading supplier in the brominated flame retardants market in China [1] - Post-transaction, Yaxing Chemical's product portfolio will expand to include brominated fine chemical products such as tetrabromobisphenol A, brominated epoxy resin, brominated polystyrene, decabromodiphenyl ether, and hydrobromic acid, along with products from Tianyi Chemical's new materials, potassium salts, and membrane materials sectors [1]

Core Viewpoint - The company, 嘉戎技术, is planning to issue shares and raise matching funds for an asset acquisition, which is expected to constitute a significant asset restructuring [2][5]. Group 1: Transaction Details - The target company for this transaction is 杭州蓝然技术股份有限公司 [5]. - Upon completion of the transaction, the main trading counterpart is expected to hold more than 5% of the listed company [5]. - The transaction is anticipated to be a related party transaction [5]. Group 2: Company Information - 杭州蓝然技术股份有限公司 was established on September 15, 2009, with a registered capital of 72.53 million yuan [6]. - The company is located at 17 Chujia Tang Road, 8th Floor, Yuhang District, Hangzhou, Zhejiang Province [6]. - The legal representative of the company is 楼永通 [6]. - The business scope includes manufacturing and sales of gas and liquid separation and purification equipment, environmental protection equipment, software development, and various technical services [6]. Group 3: Trading Suspension - The company's securities will be suspended from trading starting November 17, with an expected disclosure of the transaction plan within 10 trading days [6]. - If the company fails to hold a board meeting and disclose the transaction plan within the specified period, the securities will resume trading on December 1, and the related matters will be terminated [6].

嘉戎技术(301148)11月17日午间公告，公司正在筹划发行股份等方式购买资产事项， 同时拟募集配套资金， 预计本次交易可能构成重大资产重组。 来 源： 嘉 戎 技 术 公 告 据公告，本次交易的标的公司为杭州蓝然技术股份有限公司。 本次交易完成后，预计主要交易对方在上市公司持股比例将超过5%，本次交易预计构成关 联交易。 | 公司名称 | 杭州蓝然技术股份有限公司 | | --- | --- | | 统一社会信用代码 | 913301106945653638 | | 公司类型 | 其他股份有限公司(非上市) | | 成立日期 | 2009-09-15 | | 注册资本 | 7,253.0974 万元 | | 注册地址 | 浙江省杭州市余杭区仓前街道褚家塘路 17 号 1 幢 8 层 | | 法定代表人 | 楼永通 | | 经营范围 | 一般项目:气体、液体分离及纯净设备制造;气体、液体分离及纯净 | | | 设备销售;环境保护专用设备制造;环境保护专用设备销售;专用设 | | | 备制造(不含许可类专业设备制造);机械设备销售;仪器仪表销售; | | | 化工产品销售(不含许可类化工产品);软件开发;软件 ...